17:04 EDT Poseida Therapeutics files to sell 8.33M shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PSTX:
- Poseida Therapeutics Unveils Cancer Research Breakthroughs at AACR
- Poseida Therapeutics names Syed Rizvi, M.D., as Chief Medical Officer
- Poseida Therapeutics granted FDA orphan designation for P-BCMA-ALLO1
- Poseida Therapeutics’ treatment of multiple myeloma gets FDA orphan designation
- 3 Best Stocks to Buy Now, 3/11/2024, According to Top Analysts